CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
Therapy with CD4 and CD8 monoclonal antibodies was evaluated in dogs which received double-haplotype MHC-mismatched renal allografts. Neither CD4 nor CD8 monoclonal antibodies given alone prolonged allografts survival (creatinine > or = 300 micromol/l) beyond 7 days. However, combined therapy...
Asıl Yazarlar: | Watson, C, Cobbold, S, Davies, H, Rebello, P, Waldmann, H, Calne, R, Metcalfe, S |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1994
|
Benzer Materyaller
-
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
Yazar:: Watson, C, ve diğerleri
Baskı/Yayın Bilgisi: (1994) -
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
Yazar:: Watson, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
Yazar:: Watson, C, ve diğerleri
Baskı/Yayın Bilgisi: (1995) -
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Yazar:: Watson, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
Yazar:: Davies, H, ve diğerleri
Baskı/Yayın Bilgisi: (1994)